Example output · Healthcare Compliance Officer AI
What the MedWatch Reportability Triage actually produces
Takes a device description, adverse event narrative, patient outcome, causality hypothesis, and reporter context, then analyzes potential 21 CFR 803 reportability, drafts a Form 3500A structure, and generates escalation questions for the MDR coordinator.
- Device And Intended Use:
- Medtronic Micra AV transcatheter pacing system (leadless pacemaker); indicated for single-chamber ventricular pacing in patients with AV block
- Event Description:
- Device delivered during implant procedure but failed to sense intrinsic atrial activity post-deployment; sensing threshold could not be corrected via programmer adjustments. Device was retrieved and replaced with a second unit during the same session.
- Patient Outcome:
- Patient remained hemodynamically stable throughout; no loss of consciousness or injury. Discharged day 1 post-op with replacement device functioning normally.
- Causality Hypothesis:
- Suspected manufacturing defect in sensing electrode of the specific lot (Lot #MC-2241-A); no user or procedural error identified per electrophysiologist's assessment.
- Reporter Context:
- Compliance officer at St. Raphael Heart Institute; event flagged by EP lab nurse during post-procedure device check. Incident report filed internally. Manufacturer notified informally. No MDR submitted yet — evaluating 30-day window obligation.
REPORTER ROLE: User facility (hospital/EP lab). User-facility reporting obligations under 21 CFR 803.30 are distinct from manufacturer obligations under §803.50. The reporter must verify its role and applicable deadline with legal/compliance before filing. FACTORS POINTING TOWARD §803.50(a)(2) REPORTABILITY (if manufacturer were reporting): Device malfunctioned in sensing electrode post-deployment; malfunction was corrected only by device retrieval and replacement; suspected manufacturing defect (sensing-electrode lot). If a similar device malfunctions recurrently, sensing failure in a pacemaker could result in loss of pacing capacity and hemodynamic compromise — potential serious injury under §803.3. Same-lot clustering would heighten concern. FACTORS POINTING AWAY: Patient remained hemodynamically stable; device was retrieved and replaced during same procedure; no actual serious injury occurred; patient discharged with functional replacement. TIMELINE IF REPORTABLE: If this were a manufacturer report, §803.50 would apply: 30-day reporting timeline for events potentially resulting from malfunction. User-facility timeline under §803.30 must be verified against current CFR. CLUSTER RISK: Single event to date. Request MDR coordinator to query manufacturer database and any FAERS reports for Lot #MC-2241-A sensing failures in the past 90 days. Cluster pattern would convert single-event triage to quality-system signal (§803.17, §820.100 CAPA implications).
SECTION D (DEVICE): Medtronic Micra AV transcatheter pacing system, leadless pacemaker, model [VERIFY MODEL], Lot #MC-2241-A, serial [VERIFY SERIAL] SECTION A (PATIENT): Age [PLACEHOLDER], sex [PLACEHOLDER], weight [PLACEHOLDER]. Indication: AV block with need for single-chamber ventricular pacing. No pre-existing device. SECTION B (EVENT): Device implanted [DATE]. Post-deployment, device failed to sense intrinsic atrial activity. Programmer adjustments unable to correct sensing threshold. Clinical assessment: no user or procedural error identified. Device retrieved [TIME POST-IMPLANT]. Replacement device implanted same session, functioning normally at discharge. SECTION C (OUTCOME): Patient hemodynamically stable throughout; no loss of consciousness, syncope, or injury. Discharged postop day 1 with no adverse sequelae. SECTION E (REPORTER): St. Raphael Heart Institute (user facility). Reported by EP lab nurse; incident report filed [DATE]. Compliance officer contact: [PLACEHOLDER]. CAUSALITY STATEMENT: Suspected manufacturing defect, sensing-electrode integrity, Lot #MC-2241-A. No design or procedural causation identified.
FOR MDR COORDINATOR: (1) Confirm user-facility vs. manufacturer reporting obligation and applicable deadline under 21 CFR 803.30. (2) Query Medtronic FAERS/complaint database for Lot #MC-2241-A sensing events (past 90 days). (3) If cluster exists, escalate to quality/CAPA immediately. (4) Obtain complete device serial number and lot documentation. (5) Request device retrieved for failure analysis (sensing electrode, connector, packaging integrity). (6) Clarify whether post-implant sensing failure in leadless pacemakers is reportable-category malfunction per Medtronic's own complaint-evaluation SOP. FOR CLINICAL LEAD: (1) Was patient ever without pacing or sensing during interval between failure detection and replacement? If yes, duration and hemodynamic impact must be documented. (2) Did intraoperative sensing checks at implant verify electrode contact before closure? (3) Any complications during removal (perforation, arrhythmia, hemodynamic instability)? FOR EXTERNAL REGULATORY COUNSEL: If Lot #MC-2241-A shows cluster pattern, consider preemptive field-action notification and CAPA documentation strategy. CLUSTER CHECK: Negative to date; pending manufacturer database query. CRNA/CAPA SIGNAL: Manufacturing-process defect (electrode sensing integrity) in a single lot = process-control failure risk. Escalate to quality assurance; may trigger §820.100 requirement for retrospective analysis of same lot in field.
Replace the sample device (Micra AV), event narrative, lot number, patient outcome, and reporter context with your actual incident details. The tool's output is a triage aid — your MDR coordinator must verify the reporting role, deadlines, and final determination before any FDA submission.
Human review: MDR reportability determinations carry legal and regulatory consequences; a qualified MDR coordinator or regulatory counsel must review all outputs before any submission decision or FDA filing.
Generate this for your own situation — free.
5 runs a day, no credit card.
Try the MedWatch Reportability Triage